UAE approval for MyLan
We have the pleasure to announce the UAE Ministry of Health & Prevention (MoHAP) approval for;
Ricovir-EM® (tenofovir/emtricitabine) 300mg/200mg film-coated Tablets, 30s HDPE bottle
Ricovir-EM® is a double combination therapy for the treatment of HIV-1 infected adults.
Mylan is committed to manufacturing low-cost, high-quality generics thus contributing to affordable healthcare. Mylan is also involved in the research & development of new molecules.
Pharma Solutions is the exclusive partner of Mylan in the UAE serving all Private and Government hospitals.
